Reactions to infliximab infusions in dermatologic patients: Consensus statement and treatment protocol;Reacciones a la infusión de infliximab en pacientes dermatológicos

Actas Dermo-Sifiliograficas

Volumn 100, Issue 2, 2009, Pages 103-112

  Puig, L ^a   Saez E ^a   Lozano, M J ^a   Bordas, X ^b   Carrascosa, J M ^c   Gallardo, F ^d   Luelmo, J ^e   Sanchez Regana M ^f   Alsina, M ^g   Garcia Patos V ^h  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL DE SABADELL   (Spain)

^f HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Immunogenicity; Infliximab; Infusion reactions; Monoclonal antibody; Psoriasis

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; DIPHENHYDRAMINE; ETANERCEPT; HYDROCORTISONE; HYDROCORTISONE ACETATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INFLIXIMAB; LEVOCETIRIZINE; MERCAPTOPURINE; METHOTREXATE; PARACETAMOL; PLACEBO; PREDNISONE; STEROID;

CONSENSUS; DAY HOSPITAL; DRUG INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; MONOTHERAPY; OUTPATIENT; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 63849118067     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(09)70227-3     Document Type: Article

References (25)

1. A. Cheifetz, M. Smedley, S. Martin, M. Reiter, G. Leone, and L. Mayer The incidence and management of infusion reactions to infliximab: a large center experience Am J Gastroenterol 98 2003 1315 1324
2. P.E. Lipsky, D.M. van der Heijde, E.W. St Clair, D.E. Furst, F.C. Breedveld, and J.R. Kalden Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 343 2000 1594 1602
3. R. Mössner, and K. Reich Infliximab in the treatment of psoriasis Expert Rev Dermatol 1 2006 515 526
4. R. Saraceno, and A.B. Gottlieb Infliximab in the treatment of plaque psoriasis Therapy 4 2007 399 406
5. K. Reich, F.O. Nestle, K. Papp, J.P. Ortonne, R. Evans, C. Guzzo EXPRESS study investigators Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial Lancet 366 2005 1367 1374
6. A.B. Gottlieb, R. Evans, S. Li, L.T. Dooley, C.A. Guzzo, and D. Baker Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial J Am Acad Dermatol 51 2004 534 542
7. A. Menter, S.R. Feldman, G.D. Weinstein, K. Papp, R. Evans, and C. Guzzo A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis J Am Acad Dermatol 56 2007 31.e1 31.e15
8. C.E. Kleyn, and C.E. Griffiths Infliximab for the treatment of psoriasis Expert Opin Biol Ther 6 2006 797 805
9. W. Sandborn Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize Gastroenterology 124 2003 1140 1145
10. L. Mayer, and Y. Young Infusion reactions and their management Gastroenterol Clin N Am 35 2006 857 866
11. F. Baert, M. Noman, S. Vermeire, G. Van Assche, G. D'Haens, and A. Carbonez Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease N Engl J Med 348 2003 601 608
12. R.J. Farrell, M. Alsahli, Y.T. Jeen, K.R. Falchuk, M.A. Peppercorn, and P. Michetti Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial Gastroenterology 124 2003 917 924
13. R.N. Maini, F.C. Breedveld, J.R. Kalden, J.S. Smolen, D. Davis, and J.D. Macfarlane Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosisfactor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1998 1552 1563
14. R. Maini, E.W. St Clair, F. Breedveld, D. Furst, J. Kalden, and M. Weisman Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group Lancet 354 1999 1932 1939
15. S.B. Hanauer, C.L. Wagner, M. Bala, L. Mayer, S. Travers, and R.H. Diamond Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease Clin Gastroenterol Hepatol 2 2004 542 553
16. P. Rutgeerts, B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, and J.F. Colombel Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease Gastroenterology 126 2004 402 413
17. S.B. Hanauer, B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, J.F. Colombel ACCENT I Study Group Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 2002 1541 1549
18. B.E. Sands, F.H. Anderson, C.N. Bernstein, W.Y. Chey, B.G. Feagan, and R.N. Fedorak Infliximab maintenance therapy for fistulizing Crohn's disease N Engl J Med 350 2004 876 885
19. J. Augustsson, S. Eksborg, S. Ernestam, E. Gullström, and R. van Vollenhoven Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis Ann Rheum Dis 66 2007 1462 1466
20. T.C. Puchner, S. Kugathasan, K.J. Kelly, and D.G. Binion Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction Inflamm Bowel Dis 7 2001 34 37
21. A. Cheifetz, and L. Mayer Monoclonal antibodies, immunogenicity, and associated infusion reactions Mt Sinai J Med 72 2005 250 256
22. D.W. Hommes, B. Oldenburg, A.A. van Bodegraven, R.A. van Hogezand, D.J. de Jong, and M.J. Romberg-Camps Dutch Initiative on Crohn and Colitis (ICC). Guidelines for treatment with infliximab for Crohn's disease Neth J Med 64 2006 219 229
23. M.C. Kapetanovic, L. Larsson, L. Truedsson, G. Sturfelt, T. Saxne, and P. Geborek Predictors of infusion reactions during infliximab treatment in patients with arthritis Arthritis Res Ther 8 2006 R131
24. F. Revenga, A. Juan, I. Ros, C. Nadal, and R. Taberner Tratamiento de la psoriasis con infliximab Actas Dermosifiliogr 95 2004 44 50
25. L.L.A. Lecluse, G. Piskin, J.R. Mekkes, J.D. Bos, and M.A. de Rie Review and expert opinion on prevention and treatment of infliximab-related infusion reactions Br J Dermatol 159 2008 527 536